Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
AdaptHealth Corp Q4 2025 Earnings Call - Largest industry capitated contract goes live early, setting up 2026 revenue and margin ramp
AdaptHealth closed a year of heavy remediation and operational consolidation by standardizing workflows, pruning non-core assets, and bringing the largest capitated HME contract in the industry live a...
- Company implemented a new operating model in 2025, standardizing workflows and centralizing order intake, which management says is driving faster setups and higher conversion rates.
- Full year 2025 revenue was $3.245 billion, Q4 revenue was $846.3 million, and organic revenue growth was 1.7% for both periods, excluding dispositions and acquisitions.
- AdaptHealth set patient census records in Sleep Health, Respiratory Health, and Wellness at Home, and achieved a retention record in Diabetes Health.
- +17 more takeaways
Keurig Dr Pepper Q4 2025 Earnings Call - JDE Peet’s Deal Recasts KDP into Two Pure-Play Companies with Near-Term EPS Accretion
Keurig Dr Pepper closed 2025 with solid top-line momentum and put a stake in the ground for a strategic pivot. Full-year constant currency net sales rose 8.6%, operating income 4.9%, and EPS 7.3%. Man...
- Corporate pivot front and center: KDP launched tender offer to acquire JDE Peet’s, expects early April close, and plans to separate into Beverage Co. and Global Coffee Co. by end of 2026.
- 2025 results: constant currency net sales +8.6%, operating income +4.9%, EPS +7.3% for the full year; Q4 net sales +9.9% and Q4 EPS $0.60, up ~1.7% year over year.
- 2026 guidance inclusive of JDE Peet’s: combined net sales $25.9B–$26.4B, low double-digit constant currency EPS growth; management expects ~6–7 percentage points of EPS contribution from JDE Peet’s over three quarters.
- +12 more takeaways
Henry Schein Fourth Quarter 2025 Earnings Call - Strong Sales Momentum, Back-Loaded Cost Savings and AI-Fueled Growth Guiding 2026
Henry Schein closed Q4 2025 with the strongest sales growth in 15 quarters, driven by record global equipment sales, double-digit gains in select implant brands, and continued traction in cloud practi...
- Q4 global sales were $3.4 billion, up 7.7% year over year, with constant currency growth of 5.8% and a 1.9% FX tailwind.
- Q4 non-GAAP operating margin was 7.42%, relatively flat year over year despite slight gross margin pressure from product mix shifts.
- Q4 GAAP net income was $101 million, or $0.85 per diluted share; Q4 non-GAAP net income was $160 million, or $1.34 per diluted share.
- +15 more takeaways
Orthofix International plc Q4 2025 Earnings Call - Channel Reset Delays Targets One Year, Sets Stage for VIRATA-Fueled Spine Rebound
Orthofix closed Q4 2025 with steady top-line progress and clear operational momentum, but with one important caveat. Management completed a deliberate spine distributor channel reset that pressured ne...
- Q4 2025 pro forma net sales were $218.6 million, up 3% year-over-year, excluding the discontinued M6 disc lines.
- Global spine fixation finished the year with 10% growth; US spine fixation grew 6% for the year and 5% in Q4.
- Management executed a targeted distributor transition in 2025 that caused temporary pressure but is now largely complete; top 30 US spine distributors grew 25% year-over-year and now drive more than 75% of US net sales.
- +15 more takeaways
Novanta Q4 2025 Earnings Call - Record bookings and return to organic growth, but margins and cash hit by a deliberate regionalization choice
Novanta closed 2025 with record revenue and a clear inflection in demand, but the company paid a short-term price for customer-first execution. Q4 delivered 9% reported revenue growth, 2% organic grow...
- Q4 reported revenue grew 9% year-over-year, with 2% organic growth and 4% sequential growth; full-year 2025 revenue was $981 million, the company’s largest ever.
- Bookings jumped 25% year-over-year in Q4 and 12% sequentially, producing a company book-to-bill of 1.11; full-year bookings rose 14% with a book-to-bill of 1.01.
- New product revenue showed strong vitality, up more than 80% in Q4 and over 60% for the full year, lifting the vitality index to 24% in Q4 (22% for the year).
- +12 more takeaways
Cipher Digital Q4 2025 Earnings Call - Pivot Complete: 600 MW of Hyperscale Leases and $9.3B Contracted Revenue
Cipher used Q4 2025 to make its pivot explicit, rebranding to Cipher Digital and shifting from bitcoin mining to hyperscale HPC hosting. The company now has two signed campus leases totaling roughly 6...
- Strategic rebrand to Cipher Digital reflects a completed pivot from bitcoin mining to a pure-play digital infrastructure developer focused on hyperscale HPC.
- Cipher has executed two data center campus leases representing ~600 MW of gross capacity and approximately $9.3 billion in contracted revenue, with initial lease terms of 10 to 15 years and extension options.
- Based solely on executed contracts, management expects roughly $669 million of average annualized net operating income from October 2026 to September 2036, and projects about $754 million in annual NOI by 2035.
- +14 more takeaways
Shoals Technologies Group Fourth Quarter 2025 Earnings Call - Record Backlog Powers 2026 Growth, but Margins Face Tariff and Legal Headwinds
Shoals closed Q4 with strong top-line momentum and a company record backlog, but profit rates slipped as tariffs, elevated legal spend, and product mix pressure margins. Revenue was $148.3 million in ...
- Q4 revenue $148.3 million, up 38.6% year over year, driven by domestic project volume and newer channels.
- Full year 2025 revenue trajectory accelerated, with management saying annual revenue roughly doubled since IPO to about $475 million.
- Record backlog and awarded orders (BLAO) reached ~$747.6 million, an 18% year over year increase, with ~$603 million planned for shipment in 2026.
- +12 more takeaways
Planet Fitness Q4 2025 Earnings Call - Record Q4 openings and member gains, but 2026 guide tempered by reequip cycle and club sale
Planet Fitness closed 2025 with 20.8 million members and nearly 2,900 clubs after a banner year of expansion and member growth. The company opened 181 clubs in 2025, including a record 104 in Q4, adde...
- Planet Fitness ended 2025 with ~20.8 million members and nearly 2,900 clubs, demonstrating scale and reach.
- The company opened 181 new clubs in 2025, including a record 104 in Q4, the highest quarterly openings in company history.
- Net new members were 1.1 million in 2025, a 10% increase versus 2024 despite the first full year of higher Classic Card pricing.
- +12 more takeaways
Fulcrum Therapeutics Q4 2025 Earnings Call - Pociredir 20 mg lifts mean HbF to 19.3% with >50% reaching >=20% in 12 weeks
Fulcrum reported full 12-week data from the 20 mg cohort of the Phase 1b PIONEER trial. Pociredir produced a rapid, sizable rise in fetal hemoglobin, a doubling of F cells, reductions in hemolysis mar...
- Pociredir 20 mg once daily produced a mean absolute HbF increase of 12.2 percentage points, rising from 7.1% at baseline to 19.3% at week 12.
- Seven of 12 evaluable patients, 58%, achieved at least 20% absolute HbF by week 12, a threshold historically linked to clinical protection.
- F cell fraction roughly doubled, from about 31% at baseline to 63% at week 12, indicating broader red cell coverage.
- +12 more takeaways
AxoGen Q4 2025 Earnings Call - FDA BLA for Avance Clears Path to Scale, but Biologic Mix Will Squeeze Near-Term Margins
AxoGen closed 2025 with strong top line momentum and a strategic milestone that changes the game. Full year revenue rose 20.2% to $225.2 million, adjusted EBITDA jumped 41% to $27.9 million, and the D...
- Q4 revenue was $59.9 million, up 21.3% year over year; full year 2025 revenue was $225.2 million, up 20.2% from 2024.
- Adjusted EBITDA for 2025 rose 41% to $27.9 million, and adjusted EBITDA margin improved to 12.4% for the year, up 180 basis points year over year.
- AxoGen completed an upsized public offering in January, raising $133.3 million net, used $69.7 million to fully retire its term loan, leaving a cleaner capital structure and increased financial flexibility.
- +12 more takeaways